Accelerated Access Review – UK (closes 11th Sept)
This is the UK government review on how to get newly researched treatments and tests to patients more quickly. This might have an impact on getting future M.E. drug treatments implemented and diagnostic tests for M.E. at our GP surgeries, considering the rituximab trial and all the research into potential bio-markers.